Berends S.E., Steeg T.J.v., Ahsman M.J., Singh S,. Brandse J.F., D’Haens G.R.A.M., Mathôt R.A.A. Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients. J. Pharmacokinet. Pharmacodyn.: 5, 2019. [Link to publication]
Berends S.E., Steeg T.J.v., Ahsman M.J., Singh S,. Brandse J.F., D’Haens G.R.A.M., Mathôt R.A.A. Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients. J. Pharmacokinet. Pharmacodyn.: 5, 2019. [Link to publication]